|
IMPACT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22044604925031E-16 |
| Normal-vs-Stage2 |
1.4668000000162E-06 |
| Normal-vs-Stage3 |
3.33066907387547E-16 |
| Normal-vs-Stage4 |
1.63347113613099E-12 |
| Stage1-vs-Stage2 |
1.245380E-01 |
| Stage1-vs-Stage3 |
2.050400E-01 |
| Stage1-vs-Stage4 |
7.801200E-03 |
| Stage2-vs-Stage3 |
2.130200E-02 |
| Stage2-vs-Stage4 |
2.900400E-03 |
| Stage3-vs-Stage4 |
2.045800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.80833126250945E-12 |
| Normal-vs-AfricanAmerican |
3.56030000000507E-05 |
| Normal-vs-Asian |
6.1123328620738E-12 |
| Caucasian-vs-AfricanAmerican |
3.790800E-01 |
| Caucasian-vs-Asian |
8.946800E-01 |
| AfricanAmerican-vs-Asian |
3.754800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65201186064223E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
7.720200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62536650805123E-12 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(61-80Yrs) |
4.84756679242082E-12 |
| Normal-vs-Age(81-100Yrs) |
3.035500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.305000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.579600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.722800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.687400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.120200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.416600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.207800E-01 |
| Classical-VS-Follicular |
2.457600E-03 |
| Classical-VS-Other |
4.338800E-01 |
| Classical-VS-Normal |
3.12594394813459E-12 |
| Tall-VS-Follicular |
2.420500E-04 |
| Tall-VS-Other |
9.917600E-01 |
| Tall-VS-Normal |
1.33393296408713E-12 |
| Follicular-VS-Other |
1.288980E-01 |
| Follicular-VS-Normal |
1.51660999999637E-05 |
| Other-VS-Normal |
2.812900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33337785257481E-13 |
| Normal-vs-N1 |
7.54951656745106E-15 |
| N0-vs-N1 |
4.836000E-03 |
|
|
